New York University School of Medicine
New York, 10016, United States
NCT Number: NCT02140372
This is a pilot study. Volunteers will be given 1.8 mg (1.2 mg followed by 0.6 mg one hour later), 1.2 mg, or 0.6 mg of colchicine. Blood will be collected prior to drug administration, 2 hours after colchicine administration, and 24 hours after colchicine administration via the antecubital vein and evaluated for markers of platelet activity and inflammation.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Phase 4
New York, 10016, United States
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Colchicine 1.2 mg followed by 0.6 mg one hour later
Other names: Colcrys
Time frame: Baseline
Time frame: 2 Hours
Time frame: Baseline
In response to adenosine diphosphate
Time frame: 2 hours
In response to adenosine diphosphate
Time frame: baseline
In response to adenosine epinephrine
Time frame: 2 hours
In response to adenosine epinephrine
Time frame: Baseline
Time frame: 2 hours
NYU Langone Health
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06068257
Breast Cancer, Breast Diseases
Orlando, Florida, United States
View Trial DetailsNCT06702423
Healthy
London, United Kingdom
View Trial DetailsNCT07223164
Healthy
Irvine, California, United States
View Trial DetailsNCT05595902
Healthy
Kadıköy, Istanbul, Turkey (Türkiye)
View Trial Details